Nifty

:

14310.80

Sensex

:

47883.38

-524.05 (-3.53%)
-1707.94 (-3.44%)

Login

Nifty
Sensex

:
:

14310.80
47883.38

-524.05 (-3.53%)
-1707.94 (-3.44%)

Jubilant Pharmova Ltd.

Chemicals

Rating :

62/99

BSE: 530019 | NSE: JUBLPHARMA

Watchlist

NSE BSE

734.70

12-Apr-2021

Open
High
Low
Previous Close

751.00
793.05
706.70
735.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

671464
5110.06
1046.95
325.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

11,621.15
13.17
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

14,849.50
0.69%
1.87

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.26
9.75
6.79

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.17
9.32
5.10

PAT CAGR (%)

10 Years
5 Years
3 Years

14.61
18.05
11.80

P:E (Median)

8 Years
5 Years
3 Years

15.23
15.55
14.45

P:BV (Average)

8 Years
5 Years
3 Years

1.96
2.43
2.09

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.45
8.87
7.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 828.94 801.18 3.46% 760.75 757.54 0.42% 753.95 789.82 -4.54% 791.36 865.12 -8.53%
Expenses 707.54 706.76 0.11% 641.61 672.67 -4.62% 622.60 691.83 -10.01% 697.72 809.13 -13.77%
EBITDA 121.40 94.42 28.57% 119.14 84.87 40.38% 131.35 97.99 34.04% 93.64 55.99 67.24%
EBIDTM 14.65% 11.79% 15.66% 11.20% 17.42% 12.41% -0.29% -0.29%
Other Income 12.21 5.52 121.20% 12.89 79.08 -83.70% 8.98 5.94 51.18% 82.69 4.83 1,612.01%
Interest 22.77 34.79 -34.55% 27.21 32.29 -15.73% 39.72 32.95 20.55% 36.17 32.33 11.88%
Depreciation 29.85 28.49 4.77% 29.59 25.45 16.27% 29.53 23.66 24.81% 29.80 22.10 34.84%
PBT 80.99 34.96 131.66% 75.23 106.21 -29.17% 71.08 47.32 50.21% 110.36 6.39 1,627.07%
Tax 16.34 0.33 4,851.52% 12.60 -36.87 - 19.04 15.06 26.43% -0.82 -1.05 -
PAT 64.65 34.63 86.69% 62.63 143.08 -56.23% 52.04 32.26 61.31% 111.18 7.44 1,394.35%
PATM 7.80% 4.32% 8.23% 18.89% 6.90% 4.08% 2.87% 2.87%
EPS 4.06 2.17 87.10% 3.93 8.98 -56.24% 3.27 2.03 61.08% 6.98 0.47 1,385.11%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 1,771.34 1,517.98 16.69% 2,374.89 2,265.93 4.81% 1,892.92 2,181.86 -13.24% 2,391.41 2,385.58 0.24%
Expenses 1,278.58 1,107.56 15.44% 1,888.71 1,797.48 5.08% 1,590.70 1,747.26 -8.96% 1,854.80 2,027.61 -8.52%
EBITDA 492.76 410.42 20.06% 486.18 468.45 3.78% 302.22 434.60 -30.46% 536.61 357.97 49.90%
EBIDTM 27.82% 27.04% 20.47% 20.67% 15.97% 19.92% 14.01% 14.01%
Other Income 3.59 3.22 11.49% 7.28 12.26 -40.62% 8.13 9.70 -16.19% 19.44 -6.58 -
Interest 46.37 48.83 -5.04% 63.95 71.64 -10.73% 75.95 72.58 4.64% 71.16 61.59 15.54%
Depreciation 95.94 83.54 14.84% 115.84 116.84 -0.86% 112.30 102.69 9.36% 128.94 95.02 35.70%
PBT 343.15 248.33 38.18% 313.67 292.23 7.34% 122.10 269.03 -54.61% 355.95 -39.98 -
Tax 121.16 90.18 34.35% 89.55 42.84 109.03% 34.09 84.05 -59.44% 95.46 60.67 57.34%
PAT 221.99 158.15 40.37% 224.12 249.39 -10.13% 88.01 184.98 -52.42% 260.49 -100.65 -
PATM 12.53% 10.42% 9.44% 11.01% 4.65% 8.48% 7.11% 7.11%
EPS 19.46 12.77 52.39% 14.06 15.66 -10.22% 5.52 11.61 -52.45% 28.29 28.29 0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 3,135.00 3,139.90 3,438.61 3,306.32 2,491.22 2,656.15 3,176.30 3,672.79 3,146.30 2,641.07 2,208.48 Net Sales Growth -2.45% -8.69% 4.00% 32.72% -6.21% -16.38% -13.52% 16.73% 19.13% 19.59% Cost Of Goods Sold 1,755.44 1,684.43 2,052.81 1,771.11 1,310.23 1,453.03 1,935.90 1,982.26 1,698.14 1,397.72 1,094.63 Gross Profit 1,379.56 1,455.48 1,385.80 1,535.21 1,180.99 1,203.13 1,240.41 1,690.53 1,448.17 1,243.34 1,113.85 GP Margin 44.01% 46.35% 40.30% 46.43% 47.41% 45.30% 39.05% 46.03% 46.03% 47.08% 50.44% Total Expenditure 2,669.47 2,769.00 3,117.74 2,767.08 2,173.21 2,343.86 2,893.94 3,083.89 2,655.61 2,221.15 1,760.16 Power & Fuel Cost - 369.20 358.28 339.80 268.18 298.40 328.83 360.17 336.09 271.54 206.65 % Of Sales - 11.76% 10.42% 10.28% 10.77% 11.23% 10.35% 9.81% 10.68% 10.28% 9.36% Employee Cost - 264.90 265.71 264.42 226.31 216.18 240.83 298.23 249.02 207.23 172.81 % Of Sales - 8.44% 7.73% 8.00% 9.08% 8.14% 7.58% 8.12% 7.91% 7.85% 7.82% Manufacturing Exp. - 271.29 258.31 228.40 206.97 214.72 243.68 257.18 224.90 185.26 145.44 % Of Sales - 8.64% 7.51% 6.91% 8.31% 8.08% 7.67% 7.00% 7.15% 7.01% 6.59% General & Admin Exp. - 71.77 77.63 73.39 68.32 57.32 72.55 104.14 85.17 79.95 72.30 % Of Sales - 2.29% 2.26% 2.22% 2.74% 2.16% 2.28% 2.84% 2.71% 3.03% 3.27% Selling & Distn. Exp. - 67.66 56.30 67.72 58.18 50.59 59.06 68.71 53.13 59.50 54.24 % Of Sales - 2.15% 1.64% 2.05% 2.34% 1.90% 1.86% 1.87% 1.69% 2.25% 2.46% Miscellaneous Exp. - 39.75 48.71 22.25 35.03 53.63 13.10 13.20 9.18 19.95 54.24 % Of Sales - 1.27% 1.42% 0.67% 1.41% 2.02% 0.41% 0.36% 0.29% 0.76% 0.64% EBITDA 465.53 370.90 320.87 539.24 318.01 312.29 282.36 588.90 490.69 419.92 448.32 EBITDA Margin 14.85% 11.81% 9.33% 16.31% 12.77% 11.76% 8.89% 16.03% 15.60% 15.90% 20.30% Other Income 116.77 173.23 78.00 46.21 51.90 61.74 106.42 29.88 34.97 39.34 26.72 Interest 125.87 136.20 128.96 135.17 174.25 200.66 233.29 284.80 262.57 193.12 70.63 Depreciation 118.77 107.40 86.48 82.59 81.13 86.98 107.41 175.29 152.17 132.00 99.91 PBT 337.66 300.54 183.43 367.69 114.52 86.39 48.08 158.71 110.92 134.14 304.50 Tax 47.16 -22.30 35.80 104.25 35.33 13.39 41.19 -68.98 30.51 34.97 20.32 Tax Rate 13.97% -7.46% 19.52% 28.35% 30.85% 15.50% 16.72% 101.22% -238.17% -76.12% 6.77% PAT 290.50 321.14 147.63 263.44 79.19 73.00 205.11 0.82 -43.32 -80.92 279.63 PAT before Minority Interest 290.50 321.14 147.63 263.44 79.19 73.00 205.11 0.82 -43.32 -80.92 279.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.27% 10.23% 4.29% 7.97% 3.18% 2.75% 6.46% 0.02% -1.38% -3.06% 12.66% PAT Growth 33.62% 117.53% -43.96% 232.67% 8.48% -64.41% 24,913.41% - - - EPS 18.24 20.16 9.27 16.54 4.97 4.58 12.88 0.05 -2.72 -5.08 17.55

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 8,430.56 9,154.41 9,110.82 7,517.84 5,861.43 5,749.13 5,826.25 5,803.36 5,165.95 4,303.13 3,445.62 Net Sales Growth 0.95% 0.48% 21.19% 28.26% 1.95% -1.32% 0.39% 12.34% 20.05% 24.89% Cost Of Goods Sold 6,572.78 3,140.58 3,521.84 2,862.51 2,002.74 2,116.20 2,663.02 2,438.46 2,062.85 1,618.87 1,339.68 Gross Profit 1,857.78 6,013.84 5,588.98 4,655.33 3,858.69 3,632.94 3,163.23 3,364.90 3,103.10 2,684.26 2,105.95 GP Margin 22.04% 65.69% 61.34% 61.92% 65.83% 63.19% 54.29% 57.98% 60.07% 62.38% 61.12% Total Expenditure 6,612.79 7,207.34 7,371.81 5,999.45 4,516.14 4,502.19 5,124.71 4,782.37 4,097.81 3,412.94 2,880.76 Power & Fuel Cost - 473.80 466.38 424.91 333.66 366.71 393.04 389.74 356.73 286.89 224.04 % Of Sales - 5.18% 5.12% 5.65% 5.69% 6.38% 6.75% 6.72% 6.91% 6.67% 6.50% Employee Cost - 2,127.68 1,925.96 1,555.88 1,230.93 1,125.09 1,090.28 1,105.17 962.58 836.36 718.54 % Of Sales - 23.24% 21.14% 20.70% 21.00% 19.57% 18.71% 19.04% 18.63% 19.44% 20.85% Manufacturing Exp. - 602.62 552.26 485.98 428.84 436.46 432.40 405.14 360.48 329.75 284.66 % Of Sales - 6.58% 6.06% 6.46% 7.32% 7.59% 7.42% 6.98% 6.98% 7.66% 8.26% General & Admin Exp. - 488.39 540.75 354.56 280.98 256.23 302.28 264.23 208.35 200.72 195.72 % Of Sales - 5.34% 5.94% 4.72% 4.79% 4.46% 5.19% 4.55% 4.03% 4.66% 5.68% Selling & Distn. Exp. - 292.70 267.70 247.85 185.79 135.54 203.98 160.04 123.28 111.85 90.92 % Of Sales - 3.20% 2.94% 3.30% 3.17% 2.36% 3.50% 2.76% 2.39% 2.60% 2.64% Miscellaneous Exp. - 81.58 96.92 67.76 53.20 65.96 39.72 19.59 23.53 28.50 90.92 % Of Sales - 0.89% 1.06% 0.90% 0.91% 1.15% 0.68% 0.34% 0.46% 0.66% 0.79% EBITDA 1,817.77 1,947.07 1,739.01 1,518.39 1,345.29 1,246.94 701.54 1,020.99 1,068.14 890.19 564.86 EBITDA Margin 21.56% 21.27% 19.09% 20.20% 22.95% 21.69% 12.04% 17.59% 20.68% 20.69% 16.39% Other Income 38.44 47.43 35.74 40.03 24.86 13.37 42.45 19.06 29.87 31.48 17.24 Interest 257.43 287.41 219.81 284.28 341.11 371.35 367.61 337.11 310.93 238.23 119.99 Depreciation 453.02 461.93 370.90 415.05 291.40 346.74 287.95 281.17 253.79 220.65 180.10 PBT 1,134.87 1,245.17 1,184.04 859.08 737.64 542.22 88.43 421.78 533.29 462.79 282.02 Tax 340.26 312.29 326.80 224.66 163.02 155.40 80.48 69.64 152.36 68.41 13.37 Tax Rate 29.98% 25.80% 36.16% 26.15% 22.10% 28.66% 199.55% 33.60% 44.66% 59.95% 5.56% PAT 794.61 898.24 574.46 642.81 575.66 391.83 -57.76 109.04 152.73 14.56 229.72 PAT before Minority Interest 794.62 898.24 577.01 634.42 574.63 386.82 -40.16 137.64 188.78 45.69 227.23 Minority Interest 0.01 0.00 -2.55 8.39 1.03 5.01 -17.60 -28.60 -36.05 -31.13 2.49 PAT Margin 9.43% 9.81% 6.31% 8.55% 9.82% 6.82% -0.99% 1.88% 2.96% 0.34% 6.67% PAT Growth 61.55% 56.36% -10.63% 11.66% 46.92% - - -28.61% 948.97% -93.66% EPS 49.88 56.39 36.06 40.35 36.14 24.60 -3.63 6.84 9.59 0.91 14.42

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 2,607.30 2,340.31 2,249.38 2,042.81 2,013.73 1,944.96 1,732.75 1,843.59 1,917.10 2,140.59 Share Capital 15.93 15.93 15.93 15.93 15.93 15.93 15.45 15.93 15.93 15.93 Total Reserves 2,591.36 2,324.33 2,233.29 2,026.39 1,997.80 1,929.04 1,717.31 1,827.66 1,901.17 2,124.66 Non-Current Liabilities 1,450.86 1,225.58 1,136.68 1,428.31 1,136.80 1,988.09 1,535.29 2,543.81 2,790.51 2,459.84 Secured Loans 728.92 802.83 725.14 1,047.78 1,093.32 1,636.18 1,039.46 2,008.38 2,422.21 1,839.06 Unsecured Loans 598.99 336.74 334.24 339.24 21.51 102.89 101.59 42.87 0.00 400.00 Long Term Provisions 66.84 61.95 57.37 50.69 45.44 97.05 210.41 227.35 156.88 30.88 Current Liabilities 1,375.23 1,297.73 1,238.48 910.67 1,155.23 1,307.78 3,382.48 2,104.30 1,466.57 1,684.66 Trade Payables 618.58 596.05 749.18 486.91 364.49 507.57 599.25 515.22 706.70 415.89 Other Current Liabilities 104.65 214.28 270.24 224.33 316.73 388.02 1,468.25 465.30 186.79 143.22 Short Term Borrowings 622.97 462.71 190.64 177.07 453.94 340.43 1,097.13 1,042.70 484.73 741.21 Short Term Provisions 29.02 24.70 28.42 22.36 20.07 71.75 217.86 81.08 88.35 384.33 Total Liabilities 5,433.39 4,863.62 4,624.54 4,381.79 4,305.76 5,240.83 6,650.52 6,491.70 6,174.18 6,285.09 Net Block 1,864.72 1,491.35 1,437.81 1,421.15 1,415.24 1,445.93 2,151.14 2,185.48 1,840.07 1,538.51 Gross Block 2,288.40 1,822.01 1,684.84 1,587.18 1,501.57 2,302.83 3,243.34 3,104.96 2,613.31 2,181.11 Accumulated Depreciation 423.68 330.66 247.03 166.03 86.33 856.90 1,092.20 919.47 773.24 642.60 Non Current Assets 3,711.26 3,582.46 3,298.65 3,237.48 3,238.16 3,586.53 4,701.50 4,721.40 4,660.64 4,213.06 Capital Work in Progress 59.09 283.82 115.32 65.40 35.68 20.02 241.94 213.36 418.96 417.01 Non Current Investment 1,764.03 1,763.89 1,706.30 1,699.94 1,701.90 1,766.26 2,005.69 1,978.51 1,938.02 1,852.31 Long Term Loans & Adv. 16.03 18.02 12.27 21.80 55.41 310.60 267.34 343.84 463.22 405.23 Other Non Current Assets 7.39 25.38 26.95 29.19 29.92 43.72 35.39 0.22 0.37 0.00 Current Assets 1,722.13 1,281.17 1,325.89 1,144.31 1,067.60 1,654.31 1,949.02 1,770.30 1,513.54 2,072.03 Current Investments 0.00 0.00 0.00 9.70 7.35 0.00 0.38 0.00 21.70 11.75 Inventories 656.38 491.94 585.58 454.43 475.26 515.86 733.52 612.48 593.33 404.70 Sundry Debtors 425.45 480.52 493.66 385.67 341.30 318.76 529.60 393.25 403.82 334.52 Cash & Bank 257.73 34.74 37.51 76.66 41.05 136.74 178.71 255.88 202.83 985.26 Other Current Assets 382.57 250.13 164.36 184.96 202.64 682.95 506.82 508.68 291.86 335.80 Short Term Loans & Adv. 28.37 23.83 44.78 32.90 13.42 647.53 446.31 375.70 221.28 245.08 Net Current Assets 346.90 -16.57 87.41 233.63 -87.63 346.53 -1,433.46 -334.00 46.96 387.38 Total Assets 5,433.39 4,863.63 4,624.54 4,381.79 4,305.76 5,240.84 6,650.52 6,491.70 6,174.18 6,285.09

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 5,603.88 4,808.92 4,086.53 3,436.04 2,966.26 2,453.52 2,626.51 2,476.12 2,257.03 2,172.27 Share Capital 15.93 15.93 15.58 15.57 15.54 15.93 15.45 15.93 15.93 15.93 Total Reserves 5,587.95 4,792.94 4,070.78 3,419.98 2,950.72 2,437.59 2,611.07 2,460.19 2,241.10 2,156.34 Non-Current Liabilities 4,087.52 4,420.21 3,417.47 3,826.06 3,347.13 4,036.15 2,184.95 3,004.85 3,224.12 3,048.25 Secured Loans 728.92 811.65 729.88 1,581.96 2,620.41 3,316.29 1,716.67 1,708.74 2,839.47 2,435.91 Unsecured Loans 3,010.76 3,431.24 2,317.93 1,923.07 392.79 375.00 0.22 760.06 0.45 400.61 Long Term Provisions 150.75 114.35 107.08 80.69 70.31 67.04 219.53 237.96 169.70 39.87 Current Liabilities 2,619.01 2,089.73 2,004.69 1,684.04 2,464.44 2,129.16 3,894.41 2,778.35 2,212.79 2,269.67 Trade Payables 1,090.27 1,020.13 1,136.16 749.49 612.12 721.19 718.14 647.13 836.98 517.43 Other Current Liabilities 674.21 473.57 505.87 572.70 951.43 793.31 1,731.20 898.00 499.55 465.94 Short Term Borrowings 649.89 499.71 244.85 255.60 748.97 517.17 1,187.83 1,131.39 767.07 883.03 Short Term Provisions 204.64 96.31 117.81 106.24 151.93 97.49 257.25 101.84 109.18 403.28 Total Liabilities 12,310.41 11,318.96 9,457.17 8,898.75 8,739.70 8,618.83 8,863.81 8,370.86 7,762.89 7,532.00 Net Block 6,339.97 5,648.38 5,400.55 5,106.73 5,104.42 4,911.33 5,098.78 4,967.46 4,460.18 3,991.05 Gross Block 7,982.83 6,905.50 6,288.86 5,672.38 5,390.82 7,362.10 7,330.63 6,870.15 6,084.09 5,163.28 Accumulated Depreciation 1,642.85 1,257.12 888.31 565.66 286.40 2,450.76 2,231.85 1,902.69 1,623.92 1,172.22 Non Current Assets 7,272.06 6,734.16 6,267.41 5,950.63 5,864.37 5,904.29 5,935.78 5,809.80 5,465.57 4,940.25 Capital Work in Progress 768.39 901.43 670.97 683.78 611.32 596.60 472.39 436.89 685.55 666.71 Non Current Investment 69.36 115.11 123.52 102.71 85.43 39.50 33.99 25.61 19.20 32.75 Long Term Loans & Adv. 86.81 68.59 71.79 56.32 62.67 327.17 328.42 379.47 299.86 249.18 Other Non Current Assets 7.53 0.66 0.58 1.08 0.53 29.68 2.21 0.37 0.79 0.55 Current Assets 5,038.35 4,584.80 3,189.76 2,948.12 2,875.32 2,714.54 2,928.03 2,561.06 2,297.32 2,591.75 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1,845.38 1,417.39 1,391.39 1,220.40 1,203.10 1,235.33 1,341.42 1,116.18 1,020.22 691.28 Sundry Debtors 1,293.22 1,271.55 1,130.76 1,005.30 950.50 819.27 805.87 708.54 652.69 520.45 Cash & Bank 1,399.87 1,370.41 248.79 459.63 344.58 394.34 479.53 356.05 266.82 1,045.14 Other Current Assets 499.88 485.64 373.06 225.73 377.13 265.59 301.21 380.29 357.59 334.88 Short Term Loans & Adv. 41.33 39.80 45.75 37.06 133.06 144.56 136.04 182.01 256.70 217.50 Net Current Assets 2,419.34 2,495.07 1,185.06 1,264.08 410.88 585.38 -966.38 -217.29 84.53 322.08 Total Assets 12,310.41 11,318.96 9,457.17 8,898.75 8,739.69 8,618.83 8,863.81 8,370.86 7,762.89 7,532.00

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 316.76 181.74 557.85 419.15 164.30 285.55 548.68 827.22 405.56 239.66 PBT 298.84 183.43 367.69 114.52 86.39 246.30 -68.16 -12.81 -45.95 299.95 Adjustment 103.01 159.26 206.69 230.45 259.62 59.49 606.08 533.09 476.75 144.79 Changes in Working Capital -65.06 -112.03 41.63 79.56 -168.06 17.57 11.79 323.77 1.39 -122.92 Cash after chg. in Working capital 336.79 230.66 616.02 424.53 177.94 323.36 549.72 844.06 432.19 321.82 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 Tax Paid -20.03 -48.92 -58.17 -5.38 -13.65 -37.81 -1.04 -16.84 -26.63 -82.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -197.71 -284.79 -126.93 -43.06 521.70 1,319.35 -193.78 -399.45 -501.52 -424.69 Net Fixed Assets -241.66 -305.67 -147.58 -115.33 785.60 1,162.43 -166.96 -286.05 -434.15 -275.33 Net Investments -0.14 -57.59 3.34 -0.39 57.01 239.81 -27.56 -18.79 -95.66 5.14 Others 44.09 78.47 17.31 72.66 -320.91 -82.89 0.74 -94.61 28.29 -154.50 Cash from Financing Activity -41.05 85.28 -470.44 -338.40 -784.44 -1,646.65 -360.79 -445.73 -686.39 885.55 Net Cash Inflow / Outflow 78.00 -17.77 -39.52 37.69 -98.44 -41.75 -5.90 -17.96 -782.36 700.52 Opening Cash & Equivalents 18.70 36.47 75.99 38.29 136.74 178.49 184.38 202.34 984.70 433.75 Closing Cash & Equivalent 96.70 18.70 36.47 75.99 38.29 136.74 178.49 184.38 202.34 984.70

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 1,542.94 1,121.51 1,303.20 1,268.49 1,098.89 783.26 772.27 969.90 707.17 389.75 PBT 1,210.53 903.81 859.08 737.64 542.22 40.32 207.28 341.14 114.11 240.59 Adjustment 760.74 861.53 687.81 637.90 737.89 725.84 756.60 752.36 795.44 318.42 Changes in Working Capital -179.67 -300.53 14.15 36.88 -133.16 96.40 -110.70 -4.04 -136.91 -84.14 Cash after chg. in Working capital 1,791.60 1,464.82 1,561.04 1,412.42 1,146.96 862.57 853.18 1,089.46 772.64 474.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -248.66 -343.31 -257.84 -143.94 -48.07 -79.31 -80.91 -119.56 -65.47 -85.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -327.00 -1,011.84 -617.70 -450.39 -312.53 -343.33 -174.42 -499.72 -594.31 -352.15 Net Fixed Assets -241.66 -305.67 -147.58 -115.33 785.60 1,162.43 -166.96 -286.05 -434.15 -275.33 Net Investments -0.14 -57.59 3.34 -0.39 57.01 239.81 -27.56 -18.79 -95.66 5.14 Others -85.20 -648.58 -473.46 -334.67 -1,155.14 -1,745.57 20.10 -194.88 -64.50 -81.96 Cash from Financing Activity -1,050.37 657.43 -901.13 -685.87 -842.75 -502.69 -414.41 -449.76 -888.82 608.21 Net Cash Inflow / Outflow 165.56 767.10 -215.63 132.22 -56.38 -62.76 183.44 20.41 -775.95 645.81 Opening Cash & Equivalents 1,005.40 244.18 456.44 339.27 391.64 473.49 279.65 263.08 1,041.15 498.27 Closing Cash & Equivalent 1,230.81 1,005.40 244.18 456.44 339.27 391.63 473.49 279.65 263.08 1,041.15

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 163.69 146.93 141.21 128.22 126.43 122.11 112.20 115.75 120.36 134.39 ROA 6.24% 3.11% 5.85% 1.82% 1.53% 3.45% 0.01% -0.68% -1.30% 4.80% ROE 12.98% 6.43% 12.28% 3.90% 3.69% 11.15% 0.05% -2.30% -3.99% 12.97% ROCE 10.10% 8.10% 13.57% 7.64% 7.13% 10.35% 4.27% 5.02% 2.95% 7.96% Fixed Asset Turnover 1.53 1.96 2.04 1.70 1.47 1.20 1.20 1.14 1.14 1.08 Receivable days 52.66 51.70 48.00 50.58 43.16 46.50 44.21 44.53 49.30 51.26 Inventory Days 66.74 57.19 56.78 64.69 64.81 68.48 64.48 67.37 66.64 66.24 Payable days 78.11 80.49 81.70 70.96 68.13 68.44 64.82 55.20 40.44 50.99 Cash Conversion Cycle 41.29 28.41 23.08 44.31 39.84 46.55 43.87 56.70 75.50 66.50 Total Debt/Equity 0.75 0.73 0.63 0.83 0.90 1.17 1.91 1.77 1.53 1.40 Interest Cover 3.19 2.42 3.72 1.66 1.43 2.06 0.76 0.95 0.76 5.25

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 351.83 301.93 262.33 220.61 190.90 154.04 170.07 155.46 141.70 136.38 ROA 7.60% 5.55% 6.91% 6.52% 4.46% -0.46% 1.60% 2.34% 0.60% 3.17% ROE 17.25% 12.97% 16.87% 17.95% 14.27% -1.58% 5.39% 7.98% 2.06% 10.42% ROCE 15.07% 13.06% 15.21% 14.44% 12.42% 5.72% 7.92% 10.19% 5.79% 6.29% Fixed Asset Turnover 1.23 1.38 1.26 1.09 0.92 0.81 0.84 0.82 0.78 0.70 Receivable days 51.13 48.12 51.58 59.43 54.81 49.56 46.53 47.00 48.71 53.83 Inventory Days 65.05 56.26 63.07 73.64 75.51 78.58 75.51 73.76 71.07 71.61 Payable days 53.01 55.42 56.86 54.84 53.44 52.17 51.42 45.33 38.70 50.95 Cash Conversion Cycle 63.17 48.96 57.79 78.23 76.88 75.98 70.61 75.42 81.08 74.50 Total Debt/Equity 0.83 1.01 0.85 1.18 1.51 1.95 1.67 1.71 1.69 1.81 Interest Cover 5.21 5.11 4.02 3.16 2.46 1.11 1.61 2.10 1.48 3.01

Top Investors:

east bridge capital master fund limited

east bridge capital master fund i ltd

rakesh radheshyam jhunjhunwala

government pension fund global

rakesh radheshyam jhunjhunwala

rakesh radheshyam jhunjhunwala

Annual Reports:

News Update:

Jubilant Life Sciences raises Rs 95 crore through NCDs
14th Jan 2021, 15:27 PM

The company has allotted 950 NCDs of Rs 10,00,000 each on Private Placement basis
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback